During the period from September 2011 to March 2013, a total of 30 TB REACH grants across 24 countries designated funds to procure GeneXpert machines and the Xpert MTB/RIF assay. Of these, a ...

Lung-Protective Ventilation Ups Outcomes Post-Abdominal Op Point-of-care Xpert MTB/RIF tuberculosis testing is associated with more patients getting same-day diagnosis and having same-day treatment ...

FDA Expands Xpert MTB/RIF Test Use The Food and Drug Administration (FDA) has granted clearance for the Cepheid Xpert MTB/RIF Assay to help determine if patients with suspected tuberculosis (TB) can ...

To honor the World TB Day on Mar 24, 2015, California-based molecular diagnostics provider Cepheid CPHD along with the National Health Laboratory Services (NHLS) of South Africa, recently announced ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis in decades. David L. Cohn This molecular-based test provides a rapid and sensitive ...

Background: The identification of non-tuberculosis (TB) mycobacterial (NTM) infection remains a significant challenge. This study aims to investigate the diagnostic value of multicolour nested ...

Background. Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in low-income countries. However, little information is available on its ...

US-based leading molecular diagnostics company, Cepheid Inc - a wholly owned subsidiary of Danaher, unveiled its newest configuration in the GeneXpert family of systems, the GeneXpert Edge, in the ...

The projects were often the first implementers of the MTB/RIF test for TB case detection in their respective countries. Table 1 provides an overview of the selected nine TB REACH projects including ...